药物重整与药学服务模式用于心血管内科效果分析OACSTPCD

Objective To investigate the application effect of medication reconciliation and pharmaceutical care mode in cardiovascular medicine.Methods Based on the Part 3(Medication Reconciliation)of the Regulations for Pharmaceutical Care in Medical Institutions and the Comprehensive Medication Management Review,a medication reconciliation and pharmaceutical care mode in cardiovascular medicine was established.A total of 340 patients with cardiovascular disease admitted to the cardiovascular medicine of the hospital from March 2019 to March 2021(before the implementation of the mode)were selected as the control group,and they were given the routine pharmaceutical care mode.Another 340 patients with cardiovascular disease admitted to the hospital from April 2021 to April 2022(after the implementation of the mode)were selected as the observation group,and they were given the medication reconciliation and pharmaceutical care mode.The incidences of medication inconsistency,irrational drug use,adverse drug reactions(ADRs)and relevant drug costs between the two groups were compared.Results The proportions of changes in drug usage,dosage,variety,manufacturer and increase in variety in the observation group were significantly lower than those in the control group;the incidences of irrational medication routes,irrational drug combination,overdosage and serious ADRs in the observation group were significantly lower than those in the control group;the drug costs during hospitalization,total costs during hospitalization and drug costs after one month of discharge in the observation group were significantly less than those in the control group(P<0.05).Conclusion The application of medication reconciliation and pharmaceutical care mode in cardiovascular medicine can significantly decrease the treatment costs for patients with cardiovascular disease and effectively improve the medication safety.